BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis

References

• Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, et al. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci: Official J Soc Neurosci 24:2667–2677.
   PubMed Web of Science ®Google Scholar
• Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TM. 2003. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54:703–709.
   PubMed Web of Science ®Google Scholar
• Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29: 261–265.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Van den Eynde F, Daskalakis ZJ. 2013. Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials. Depress Anxiety 30:614–623.
   PubMed Web of Science ®Google Scholar
• Berrouschot J, Rolle K, Kuhn HJ, Schneider D. 1997. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. J Neurol Sci 150:173–176.
   PubMed Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, et al. 2006. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharm: J Eur College Neuropsychopharm 16: 620–624.
   PubMed Web of Science ®Google Scholar
• Bolwig TG. 2011. How does electroconvulsive therapy work?Theories on its mechanism. Can J Psychiatry. Revue Can Psychiatrie 56:13–18.
   PubMed Web of Science ®Google Scholar
• Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99–125.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Lopes M, Fregni F. 2008. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11:1169–1180.
   PubMed Web of Science ®Google Scholar
• Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.
   Google Scholar
• Dwork AJ, Christensen JR, Larsen KB, Scalia J, Underwood MD, Arango V, et al. 2009. Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience 164:1557–1564.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634.
   PubMed Web of Science ®Google Scholar
• Esel E, Kose K, Hacimusalar Y, Ozsoy S, Kula M, Candan Z, Turan T. 2008. The effects of electroconvulsive therapy on GABAergic function in major depressive patients. J ECT 24:224–228.
   PubMed Web of Science ®Google Scholar
• Fernandes B, Gama CS, Massuda R, Torres M, Camargo D, Kunz M, et al. 2009. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci Lett 453:195–198.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, et al. 2011. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45:995–1004.
   PubMed Web of Science ®Google Scholar
• Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R. 2012. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 3:12.
   PubMedGoogle Scholar
• Giese M, Unternaehrer E, Brand S, Calabrese P, Holsboer-Trachsler E, Eckert A. 2013. The interplay of stress and sleep impacts BDNF level. PLoS One 8:e76050.
   PubMed Web of Science ®Google Scholar
• Gronli O, Stensland GO, Wynn R, Olstad R. 2009. Neurotrophic factors in serum following ECT: a pilot study. World J Biol Psychiatry: Off J World Fed Soc Biol Psychiatry 10: 295–301.
   PubMed Web of Science ®Google Scholar
• Group UER. 2003. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:799–808.
   PubMed Web of Science ®Google Scholar
• Haghighi M, Salehi I, Erfani P, Jahangard L, Bajoghli H, Holsboer-Trachsler E, et al. 2013. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. J Psychiatr Res 47:908–915.
   PubMed Web of Science ®Google Scholar
• Hedges LV, Olkin I. 1985. Statistical methods for meta-analysis. Orlando, FL: Academic Press.
   Google Scholar
• Higgins J, Green S.Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. (updated september 2009). [Internet]. The Cochrane Collaboration, 2008; 2009.
   Google Scholar
• Hu Y, Yu X, Yang F, Si T, Wang W, Tan Y, et al. 2010. The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J ECT 26:121–125.
   PubMed Web of Science ®Google Scholar
• Karege F, Schwald M, Cisse M. 2002. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264.
   PubMed Web of Science ®Google Scholar
• Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, et al. 2010. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry: J Mental Sci 196:226–234.
   PubMed Web of Science ®Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5:e45.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Nestler EJ. 2010. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167: 1305–1320.
   PubMed Web of Science ®Google Scholar
• Kuipers SD, Trentani A, Den Boer JA, Ter Horst GJ. 2003. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 85:1312–1323.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100.
   Web of Science ®Google Scholar
• Lin CH, Chen MC, Lee WK, Chen CC, Huang CH, Lane HY. 2013. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients. Neuropsychobiology 68:110–115.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, et al. 2007. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61:142–144.
   PubMed Web of Science ®Google Scholar
• Marano CM, Phatak P, Vemulapalli UR, Sasan A, Nalbandyan MR, Ramanujam S, et al. 2007. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 68:512–517.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. 2014. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N = 9484).Mol Psychiatry 19:791–800.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Inoue Y, et al. 2008. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Progr Neuro-Psychopharm Biol Psychiatry 32:1185–1190.
   PubMed Web of Science ®Google Scholar
• Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E, et al. 2010. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein. Psychiatry Res 177: 97–100.
   PubMed Web of Science ®Google Scholar
• Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. 1998. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553–1561.
   PubMed Web of Science ®Google Scholar
• Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, et al. 2009. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharm: J Eur College Neuropsychopharm 19:349–355.
   PubMed Web of Science ®Google Scholar
• Schule C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, et al. 2006. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31:1019–1025.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527–532.
   PubMed Web of Science ®Google Scholar
• Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, et al. 2013. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharm: J Eur College Neuropsychopharm 23:1199–1207.
   PubMed Web of Science ®Google Scholar
• Swartz CM, Nelson AI. 2005. Rational electroconvulsive therapy electrode placement. Psychiatry 2:37–43.
   PubMedGoogle Scholar
• Thase ME, Rush AJ. 1997. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 58(Suppl 13):23–29.
   PubMed Web of Science ®Google Scholar
• Wahlund B, von Rosen D. 2003. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharm: Official Publ Am College Neuropsychopharmacol 28(Suppl 1):S212–216.
   Google Scholar
• Zunhammer M, Langguth B, Landgrebe M, Frank E, Muller S, Burger J, et al. 2011. Modulation of human motor cortex excitability by valproate. Psychopharmacology 215: 277–280.
   PubMed Web of Science ®Google Scholar